cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Repare Therapeutics Inc
9 own
11 watching
Current Price
$10.3
$0.11
(1.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
432.97M
52-Week High
52-Week High
18.68
52-Week Low
52-Week Low
8.31
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization432.97M
icon52-Week High18.68
icon52-Week Low8.31
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Repare Therapeutics Inc do?
N/A
Read More
How much money does Repare Therapeutics Inc make?
News & Events about Repare Therapeutics Inc.
Business Wire
1month ago
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today presented initial data from its ongoing Phase 1/2 TRESR clinical trial evaluating camonsertib (RP-3500/RG6526, partnered with Roche), a potent and selective oral small...
Globe Newswire
3 months ago
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX PR Newswire NEW YORK, Feb. 13, 2023 NEW YORK, Feb. 13, 2023...
Business Wire
3 months ago
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Investors who purchased Repare securities are encouraged to obtain additional information and assist the...
Zolmax
3 months ago
Morgan Stanley cut shares of Repare Therapeutics (NASDAQ:RPTX Get Rating) from an overweight rating to an equal weight rating in a report released on Friday, MarketBeat reports. The firm currently has $15.00 price objective on the stock, down from their previous price objective of $28.00. A number ...
Frequently Asked Questions
Frequently Asked Questions
What is Repare Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Repare Therapeutics Inc shares?
plus_minus_icon
How can I buy Repare Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Repare Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Repare Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Repare Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Repare Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Repare Therapeutics Inc?
plus_minus_icon
What percentage is Repare Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Repare Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.3
$0.11
(1.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PULMONX CORP
PULMONX CORP
$11.52
$-0.02 (-0.17 %)
Valneva SE
Valneva SE
$11.55
$-0.07 (-0.65 %)
Zomedica Corp
Zomedica Corp
$0.19
$0.00 (2.58 %)
Fusion Pharmaceuticals Inc
Fusion Pharmaceuticals Inc
$4.23
$-0.02 (-0.47 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
PULMONX CORP
PULMONX CORP
$11.52
$-0.02 (-0.17 %)
Valneva SE
Valneva SE
$11.55
$-0.07 (-0.65 %)
Zomedica Corp
Zomedica Corp
$0.19
$0.00 (2.58 %)
Fusion Pharmaceuticals Inc
Fusion Pharmaceuticals Inc
$4.23
$-0.02 (-0.47 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00